State-of-the-Art of Monoclonal Antibodies for the Treatment of Gastric Cancer
Debora Basile,1 Francesca Simionato,1 Alessandro Cappetta,1 Silvio Ken Garattini,2 Giandomenico Roviello,3 Giuseppe Aprile1 1Department of Oncology, San Bortolo General Hospital, AULSS8 Berica, Vicenza, Italy; 2Department of Oncology, University Hospital, Udine, Italy; 3Department of Health Sciences...
Enregistré dans:
Auteurs principaux: | Basile D, Simionato F, Cappetta A, Garattini SK, Roviello G, Aprile G |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f80be8f1068040e88043836502cb1a78 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Association of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas
par: Antonio Pellino, et autres
Publié: (2021) -
Biological Significance and Targeting of the FGFR Axis in Cancer
par: Athina-Myrto Chioni, et autres
Publié: (2021) -
The association between gastric acid inhibitors and delirium in geriatric inpatients: implications for clinical practice and research
par: Zhu LL, et autres
Publié: (2016) -
Anti-cancer effects of 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives on hepatocellular carcinoma harboring FGFR4 activation
par: Yunju Nam, et autres
Publié: (2022) -
Diffuse scaly erythematous plaques in patient taking poziotinib
par: Reid Oldenburg, MD, PhD, et autres
Publié: (2022)